Protein Destabilizer Selection via Cell Survival Assay

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional reporter assays for identifying agents that downregulate proteins of interest often suffer from spurious results due to more trivial ways to downregulate than upregulate, leading to artifacts and inefficiencies in identifying effective destabilizing agents.

Innovation Solution

Development of 'up' assays that utilize cell survival as a positive indicator by employing recombinant fusion constructs with a cytotoxic element fused to a protein of interest, where the degradation of the fusion construct promotes cell survival, allowing for the identification of test agents that destabilize the protein of interest through increased cell viability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional down assays are used to identify agents that downregulate proteins of interest, then the ability to detect protein downregulation is achieved, but spurious results and artifacts increase due to more trivial ways to downregulate than upregulate

Engineering Contradiction:
Improveaccuracy of hit identificationVSAvoidartifact reduction
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent inverts the conventional down assay approach by creating an up assay where cells express a fusion protein containing both the protein of interest and a cytotoxic element. Instead of detecting decreased signal from protein downregulation, the assay detects increased cell survival when the protein is destabilized. This inversion transforms a negative selection assay prone to artifacts into a positive selection assay with improved reliability and fewer spurious results.

Inventive Principle:
Principle #13The other way round (Inversion)

2Difficulty of detecting and measuring

If down assays measure decrease in reporter protein signal to identify hits, then the ability to detect protein downregulation is achieved, but the complexity of distinguishing true hits from artifacts increases

Engineering Contradiction:
Improvehit detection complexityVSAvoidsignal interpretation accuracy
Core Design Contradiction:
Difficulty of detecting and measuringVSMeasurement precision

Solution Approach 1:

The patent converts the harmful cytotoxic element into a beneficial reporting mechanism. By fusing the cytotoxic element to the protein of interest, the harmful effect (cell death) becomes the useful signal for detecting protein stability. When the protein is destabilized, the cytotoxic element is also degraded, leading to cell survival. This transformation simplifies hit detection by converting a complex signal interpretation problem into a straightforward cell survival readout.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The 'up' assays effectively identify test agents that destabilize proteins of interest by using cell survival as a positive selection method, reducing artifacts and improving the accuracy of hit identification in high-throughput screening.

Implementation Method 1

providing cells expressing a recombinant fusion protein comprising a POI and an enzyme, wherein the enzyme converts an exogenous substrate that is not toxic to the cells into a product that is toxic to the cells

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentUS20220357311A1Methods and compositions for the positive selection of protein destabilizers
Publication Date: 2022.11.10 DANA FARBER CANCER INSTITUTE INC
  • US20220357311A1 patent drawing
  • US20220357311A1 patent drawing
  • US20220357311A1 patent drawing

AI summary

The present application relates, in some aspects, to the development of an assay that uses cell survival and/or cell viability as a phenotypic identifier to positively select for agents that destabilize a protein of interest.